Neoplasm by Morphology — Trials

Neoplasm by Morphology — Trials · CancerIndex

Clinical trials

Registered studies

52,671 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 501–550 of 20,434 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02724488	Selection Pressure and Evolution Induced by Immune Checkpoint Inhibitors and Other Immunologic Therapies(SPECIAL)	completed	—	14	University Health Network, TorontoOTHER	0	Jul 14, 2026	clinicaltrials
NCT02752035	A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy	completed	Phase 3	183	Astellas Pharma Global Development, Inc.